Abstract
Prompted by successful genetic interventions in aging we now consider the utility of pharmacological interventions. A few clear cases of lifespan extension resulting from exposure to compounds suggest that aging can be slowed and that the pharmacology of lifespan extension is a feasible area for research. Compounds that slow aging may prompt the rational design of therapeutics against age-related diseases. Here we evaluate invertebrate models for drug discovery in aging and outline how the field may develop from these simple first steps.
Original language | English (US) |
---|---|
Pages (from-to) | 213-223 |
Number of pages | 11 |
Journal | AGE |
Volume | 27 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2005 |
Externally published | Yes |
Keywords
- Aging
- Anti-aging drugs
- Antioxidant
- Invertebrates
- Lifespan
- Pharmacology
- Stress